Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)
CUSIP: 603380205
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 45,675,986
- Total 13F shares
- 1,979,675
- Share change
- +35,209
- Total reported value
- $4,208,645
- Price per share
- $2.10
- Number of holders
- 22
- Value change
- +$81,860
- Number of buys
- 8
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 603380205:
Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,275,000
|
$4,794,000 | — | 27 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
3%
|
1,351,275
|
$2,324,193 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
252,060
|
$433,544 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.24%
|
111,000
|
$190,920 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
75,625
|
$130,099 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.16%
|
72,669
|
$124,991 | — | 30 Jun 2025 | |
| Apella Capital, LLC |
13F
|
Company |
0.05%
|
20,939
|
$34,340 | — | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
17,416
|
$29,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
16,519
|
$28,413 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.03%
|
12,406
|
$21,338 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
11,008
|
$18,933 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,215
|
$3,810 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
875
|
$1,505 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
162
|
$279 | — | 30 Jun 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
100
|
$172 | — | 30 Jun 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
100
|
$172 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
62
|
$107 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
57
|
$101 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
53
|
$91 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
25
|
$43 | — | 30 Jun 2025 | |
| Anchor Investment Management, LLC |
13F
|
Company |
0%
|
12
|
$21 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
605,230
|
— | — | 11 Aug 2022 | |
| Jeryl L. Hilleman |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 27 Sep 2023 | |
| William F. Doyle |
3/4/5
|
Director |
—
class O/S missing
|
2,500
|
— | — | 10 Jun 2022 |
Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.